Research and Training Committee (RTC)



Lucy OsborneChairBio
Dr. Osborne received her PhD from The University of London, England (1993) and completed post-doctoral training in human genetics with Prof. Lap-Chee Tsui at the Hospital for Sick Children, Toronto. She was appointed at the University of Toronto in 1999 and is currently a Professor in the departments of Medicine and Molecular Genetics. The major focus of Dr. Osborne’s research is chromosome rearrangements of human chromosome 7q11.23, with the aim of understanding the molecular basis of the resulting neurodevelopmental disorders. Her lab is at the forefront of research into the deletion disorder Williams syndrome, as well as it’s reciprocal duplication disorder, and has helped elucidate the range of complex chromosomal rearrangements associated with this part of chromosome 7. Her team are currently using both human participants and animal models to probe the molecular and cellular bases of cognitive and behavioural aspects of these syndromes with the long term goal of developing targeted therapeutic options. Dr. Osborne is currently chair of the Kids Brain Health Network Research Training Committee.
Christian BeaulieuMemberBio
Dr. Christian Beaulieu is a Professor of Biomedical Engineering, Scientific Director of the Peter S Allen MRI Research Centre at the University of Alberta, and an Alberta Innovates – Health Solutions Scientist. His research expertise lie in the development of new magnetic resonance imaging (MRI) methods, specifically for the study of white matter tracts, and their application to better detect differences of the human brain with typical neurodevelopment and in individuals with neurological disorders. His role in Kids Brain Health Network is to coordinate the MRI acquisition of children and adolescents with fetal alcohol spectrum disorders over a number of sites across Canada.
Richard BrownMemberBio
Dr. Brown's lab is funded for work in behavioural neuroscience. Current projects include: Animal models of Alzheimers Disease; Behavioural analysis of transgenic and mutant mice; the JAX Phenome Project which involves involves behavioural phenotyping for differences in anxiety, locomotor behaviour and spatial learning in 14 strains of mice; psychopharmacology and behavioural development in rodents; Methylphenidate and behaviour; olfactory communication and olfactory learning; and parental behaviour in rodents.
David EisenstatMemberBio
Dr. Eisenstat’s research involves understanding the regulation of cell growth and differentiation during development. Biological response modifiers have been used to treat several types of malignancy by harnessing normal developmental programs specific to these relatively undifferentiated cancer cell populations. The aim is to facilitate understanding of the processes of cell differentiation through improved understanding of two important regulatory molecules: (i) hypoxia-inducible cell death protein, BNIP3 (ii) the DLX homeodomain proteins. Ultimately, they hope to develop novel therapeutic approaches by modifying neuronal differentiation programs in paediatric malignancies.
Kathryn MurphyMemberBio

Information to come soon

Bryan RichardsonMemberBio
Dr. Bryan Richardson is a Professor in the Departments of Obstetrics and Gynaecology, Physiology and Pharmacology, and Pediatrics at The University of Western Ontario, and a Scientist in the Fetal and Newborn Health Program of the Children’s Health Research Institute in London, Ontario. He has had longstanding support from the MRC/CIHR, initially as an MRC Fellow and subsequently a Scholar, and with continuous national funding for over 25 years, most recently as a member of the CIHR Group in Fetal Growth Restriction: Mechanisms and Outcomes. He is currently investigating the impact of maternal undernourishment leading to fetal growth restriction with chronic hypoxia on later development focusing on the brain. Dr. Richardson is recognized for his research contributions internationally having published 143 peer-reviewed medical articles, and 20 book chapters/symposia proceedings. He has supervised and mentored 41 research trainees, many of whom subsequently have taken up academic faculty positions here in Canada and in Japan. He was the first WYETH AYERST Canada/CIHR Clinical Research Chair in Women’s Health for Perinatology, and subsequently a recipient of a Canada Research Chair (Tier 1) in Fetal and Neonatal Health and Development (2004-2011). As further indication of his stature in the area of perinatal physiology and clinical practice, Dr. Richardson was voted to the Executive Council of the Perinatal Research Society, and subsequently served as its President. He also served on the Executive Council of the Fetal and Neonatal Physiological Society, and on the inaugural Advisory Board for the CIHR Institute of Human Development, Child and Youth Health during which time he led the research agenda for Healthy Pregnancies. Dr. Richardson has been a reviewer for several scientific medical journals in the fields of Obstetrics/Gynaecology and Perinatal Physiology, and presently serves on the editorial boards for Early Human Development and Reproductive Sciences. He additionally has served as a committee member for several granting agencies including March of Dimes, and the MRC/CIHR Clinical Investigation A Committee. Dr. Richardson also served as Academic Chair of Western’s Department of Obstetrics and Gynaecology from 2004 until 2012, overseeing a period of substantial growth and promoting academic excellence and funding partnerships.
Jill ZwickerMemberBio
Dr. Jill Zwicker is an Assistant Professor in the Department of Occupational Science and Occupational Therapy and an Associate Member in the Department of Pediatrics at the University of British Columbia. In addition, Jill is a Scientist (Level 1) at the Child and Family Research Institute, a Clinician Scientist at Sunny Hill Health Centre for Children, an Affiliate Investigator with Kids Brain Health Network, and a Research Associate with CanChild Centre for Childhood Disability Research. Dr. Zwicker has received multiple awards including a Michael Smith Foundation for Health Research Scholar Award, and a Career Enhancement Award from the Canadian Child Health Clinician Scientist Program.